2025 BioTech Digital Health 
Lloyd Price
FEBRUARY 23, 2025
Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6
Lloyd Price
MARCH 1, 2025
Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. The increase of distressed company M&A's is a large factor in the 2025 market. Average revenue multiples The average revenue multiple for HealthTech companies in March 2025 is 4.8x. This is down from 6.5x
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
DECEMBER 11, 2024
With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. Gerresheimer expects the acquisition to be accretive to the Group’s Adj. EBITDA margin and Adj.
Digital Health Global
APRIL 8, 2025
Comprehensive wellness app combines fingernail selfie technology with new circulation function and features for holistic health tracking PEACHTREE CORNERS, Ga.–(BUSINESS Existing AnemoCheck Mobile users will automatically begin transitioning to Ruby when the app updates on April 1, 2025. Ruby Premium will be available at $12.99
Lloyd Price
DECEMBER 2, 2024
The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. Digital Health Solutions: Digital health solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making.
Digital Health Global
NOVEMBER 30, 2023
Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.
Healthcare IT Today
MARCH 13, 2025
With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech. Originally announced February 3rd, 2025 Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience.
Expert insights. Personalized for you.
76 
Let's personalize your content